Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03494166 · ClinicalTrials.gov registry record · NA

Post-chemotherapy Symptom Management SMART

A NA study of Cancer, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
498
Enrollment target
2
Study locations

NCT03494166 is a NA study of Cancer that has completed, run by University of Arizona. The registered enrollment target is 498 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03494166, a NA study of Cancer, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
498 participants
Enrollment target
2
Study locations

Study Summary

Survivors of solid tumors (N=451) who completed curative intent chemotherapy for a solid tumor within the past 2 years were interviewed at baseline and stratified as high or low need for symptom management based on comorbidity and depressive symptoms. High need survivors were randomized initially to the 12-week Symptom Management and Survivorship Handbook (SMSH, N=282) or 12-week SMSH Telephone Interpersonal Counseling (TIPC, N=93) added during weeks 1-8. After 4 weeks of the SMSH alone, non-responders on depression were re-randomized to continue with SMSH alone (N=30) or add TIPC (N=31).

Conditions Studied

Interventions

  • BEHAVIORAL Start with SMSH+TIPC
  • BEHAVIORAL Start with SMSH alone

Study Locations (2)

Arizona

  • Cancer Center at St. Joseph's - Phoenix
  • University of Arizona - Tucson

Trial Details

FieldValue
Enrollment Target 498 participants
Start Date 2018-07-01
Est. Completion 2022-06-03
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT03494166

The ClinicalTrials.gov registry entry for NCT03494166 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 498 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Start with SMSH+TIPC is the first listed.

NCT03494166 reports 2 study locations spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT03494166 about?

NCT03494166 is a clinical study titled "Post-chemotherapy Symptom Management SMART". Survivors of solid tumors (N=451) who completed curative intent chemotherapy for a solid tumor within the past 2 years were interviewed at baseline and stratified as high or low need for symptom management based on comorbidity and depressive symptoms. High need survivors were randomized initially t...

What is the current status of trial NCT03494166?

This trial is currently completed. It is a NA study. The enrollment target is 498 participants. The study started on 2018-07-01. Estimated completion is 2022-06-03.

What conditions does trial NCT03494166 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT03494166?

The interventions under investigation include: Start with SMSH+TIPC (BEHAVIORAL), Start with SMSH alone (BEHAVIORAL).

Who is sponsoring clinical trial NCT03494166?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03494166 being conducted?

This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.